Author | Erin Kayata

September 27, 2019

The Global Burden of Disease 2017 study found non-melanoma skin cancer to be the biggest increase in incidence worldwide.

September 24, 2019

As more younger adults are diagnosed with colorectal cancer, the FDA approved Cologuard, a stool-based, at-home colorectal cancer screening, for adults aged 45 to 49 years.

September 18, 2019

Apalutamide was initially approved in 2018 for patients with non-metastatic castration-resistant prostate cancer; the recent approval is for patients with metastatic castration-sensitive prostate cancer.

September 17, 2019

The combination was simultaneously approved in Australia and Canada and was the first such action under a new international collaboration.